Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8729037

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8722063

Vaccination of animals to elicit a protective immune response against tick infestations an

The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8712696

Methods of prognosing a rheumatoid arthritis remission phenotype

PROGENIKA BIOPHARMA, S.A. · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8710031

Compounds for nonsense suppression and methods for their use

PTC THERAPEUTICS, INC. · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697048

Peptide amphiphile suspension to prevent or reduce tumor formation from administered embry

Northwestern University · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8695119

Coated elastomeric article and method for making a coated elastomeric article

Precision Components, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691967

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

Benitec, Inc. · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691872

Dispersions of rasagiline citrate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691786

Methods and compositions for the specific inhibition of gene expression by double-stranded

INTEGRATED DNA TECHNOLOGIES, INC. · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685929

Detecting CYP24 expression level as a marker for predisposition to cancer

The Regents of the University of California · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680113

BMI-1 protein expression modulators

PTC THERAPEUTICS, INC. · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8664193

Compositions and methods for inhibiting expression of factor VII gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658356

Methods and compositions for the specific inhibition of gene expression by double-stranded

INTEGRATED DNA TECHNOLOGIES, INC. · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658778

hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer

The Board of Regents of the University of Texas System · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8652443

Foamable microemulsion compositions for topical administration

Precision Dermatology, Inc. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8648100

Roflumilast for the treatment of pulmonary hypertension

TAKEDA GMBH · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8647842

Methods for producing a fusion protein capable of binding VEGF

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8632751

Scanning suspension comprising a particle with a diameter of at least 1 micrometer

Universitair Medisch Centrum Utrecht · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8633034

Methods for evaluating the aggregation of a protein in a suspension including organopolysi

The Regents of the University of Colorado · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8623330

Emollient foams for treatment of seborrheic dermatitis

Precision Dermatology, Inc. · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8617557

Antibody fusion with IL-12 proteins with disrupted heparin-binding activity

The Regents of the University of California · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8614198

Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609728

Treatment for pulmonary hypertension

United Therapeutics Corporation · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609067

Method of measuring propulsion in lymphatic structures

The Board of Regents of the University of Texas System · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted